Skip to main content

Innovation. Clarity. Execution.  I  Exit History

Exit History.

Delivering Value

2022

Filter

MiroBio

Exited

2021

Filter

Axonics

Share sale

Centessa

IPO NASDAQ

Aura

IPO NASDAQ

2020

Filter

Acutus

IPO NASDAQ

Axonics

Share sale

Kandy

Aquired by Bayer $875M + milestones

2019

Filter

CardiAQ

Acquired by Edwards Lifesciences Corporation USD $400M

Axonics

Share Sale

2018

Filter

Iterum

IPO NASDAQ

Axonics

Share Sale

2017

Filter

Conatus

Share sale

2016

Filter

SEP

Acquired by Juno Aspire Pharma

Biocartis

IPO EURONEXT

2015

Filter

Biocartis

IPO EURONEXT

Cellnovo

IPO EURONEXT

CardiAQ

Milestone

UniQure

Share sale

2014

Filter

Agenus

4-Antibody acquired by Agenus

Algeta

Acquired by Bayer USD $2.9B

UniQure

IPO NASDAQ

Aravive

IPO NASDAQ

2013

Filter

CN

Acquired by British American Tobacco

Conatus

IPO NASDAQ

Santarus

Acquired by Salix Pharmaceuticals Inc. USD $2.6B

2012

Filter

Micromet

NASDAQ. Acquired by Amgen USD$1.1b

Avila

Acquired by Celgene USD$350m + USD$575m milestones

EUSA

Acquired by Jazz Pharmaceuticals USD$700m

2011

Filter

Cardiokine

Acquired by Cornerstone

2010

Filter

Respivert

Acquired by J&J

2009

Filter

Emergent

Merged with Microscience

2008

Filter

Thiakis

Acquired by Wyeth Pharmaceuticals USD$150m

2007

Filter

Algeta

IPO Oslo Børs

2006

Filter

Infinity

NASDAQ

PowderMed

Acquired by Pfizer

The companies in which we have invested since the year 2006 have discovered and developed, fourteen approved medicines and products to the benefit of patients, physicians and our investors.

Portfolio

About

Leading Venture Investors
Learn More

Portfolio

Innovative Life Sciences Companies
Learn More